Chemoradiotherapy for head and neck cancer: Current status and perspectives

International Journal of Clinical Oncology

Volumn 9, Issue 6, 2004, Pages 421-434

  Kawashima, Mitsuhiko ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Chemotherapy; Head and neck cancer; Multidisciplinary approach; Radiotherapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; VINDESINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DOSE RESPONSE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY OF LIFE; RADIATION DOSE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS; SALVAGE THERAPY;

EID: 12444301811     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0445-x     Document Type: Review

References (128)

1. O'Sullivan B, Mackillop W, Gilbert R, et al. (1994) Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol 31:23-32
2. Groome PA, O'Sullivan B, Irish JC, et al. (2003) Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance. Epidemiology, and End Results areas of the United States. J Clin Oncol 21:496-505
3. Colledge L (1938) Treatment of carcinoma in the pharynx and larynx and its results. BMJ 2:167-178
4. Keane TJ, Hawkins NV, Beale FA, et al. (1983) Carcinoma of the hypopharynx results of primary radical radiation therapy. Int J Radiat Oncol Biol Phys 9:659-664
5. Shah JP, Shah AR, Spiro RH, et al. (1976) Carcinoma of the hypopharynx. Am J Surg 134:489-491
6. Ogura JH, Marks JE, Freeman RB (1980) Results of conservation surgery for cancers of the supraglottis and pyriform sinus. Laryngoscope 90:591-600
7. Berkley HT, Fletcher GH, Jesse RH, et al. (1972) Management of lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124:462-467
8. Bartelink H, Breur K, Hart G, et al. (1983) The value of post-operative radiotherapy as an adjuvant to radical neck dissection. Cancer 52:1003-1008
9. Cachin Y, Eschwege F (1975) Combination of radiotherapy and surgery in the treatment of head and neck cancer. Cancer Treatment Rep 2:177-191
10. Marcus RB, Million RR, Cassisi NJ, et al. (1979) Postoperative irradiation for squamous cell carcinoma of the head and neck: analysis of time-dose factors related to control above the clavicle. Int J Radiat Oncol Biol Phys 5:1943-1949
11. Vickram B, Strong E, Shah JP, et al. (1984) Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:724-729
12. Kramer A, Gelber RD, Snow JB, et al. (1987) Combined radiation therapy and surgery in the management of head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10:19-30
13. El Badawi SA, Goepfert H, Fletcher GH, et al. (1982) Squamous cell carcinoma of the pyriform sinus. Laryngoscope 92:357-364
14. Persky MS, Daly JF (1981) Combined therapy vs curative radiation in the treatment of pyriform sinus carcinoma. Otolaryngol Head Neck Surg 89:87-91
15. Vandenbouck C, Eschwege F, De La Rochefordiere A, et al. (1987) Squamous cell carcinoma of the pyriform sinus: retrospective study of 351 cases treated at the Institut Gustave-Roussy. Head Neck Surgery 10:4-13
16. Kim S, Wu HG, Heo DS, et al. (2001) Advanced hypopharyngeal carcinoma: treatment results according to treatment modalities. Head Neck 23:713-717
17. Kraus DH, Zelefsky MJ, Brock HA, et al. (1997) Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 116:637-641
18. Beauvillain C, Mahe M, Bourdin S, et al. (1997) Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinoma. Laryngoscope 107:648-653
19. Zelefsky MJ, Harrison LB, Armstrong JG (1992) Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer 70:2388-2395
20. Lefebvre JL, Chevalier D, Lubinski B, et al. (1996) Larynx preservation in pyriform sinus cancer: preliminary results of European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899
21. Zelefsky MJ, Kraus DH, Pfister DG, et al. (1996) Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 18:405-411
22. Spector JG, Sessions DG, Emami B, et al. (1995) Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long term results. Laryngoscope 105:397-406
23. Mendenhall WM, Amdur RJ, Stringer SP, et al. (2000) Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? J Clin Oncol 18:2219-2225
24. Ries LAG, Wingo PA, Miller DS, et al. (2000) The annual report to the nation on the status of cancer. 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-424
25. Scanlon PW, Soule EH, Devine KD, et al. (1969) Cancer of the base of the tongue: 116 patients treated radiotherapeutically in the 11 year period 1952 through 1962. AJR Am J Roentgenol 105:26-36
26. Perez CA, Lee FA, Ackerman LV, et al. (1976) Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic lymph nodes. Int J Radiat Oncol Biol Phys 1:817-827
27. Tong D, Laramore GE, Griffin TW, et al. (1982) Carcinoma of the tonsillar region: results of external irradiation. Cancer 49:2009-2014
28. Spanos WJ, Shukovsky LJ, Fletcher GH (1976) Time, dose, and tumor volume relationships in irradiation of squamous cell carcinoma of the base of the tongue. Cancer 37:2591-2599
29. Amdur RJ, Mendenhall WM, Parsons JT, et al. (1987) Carcinoma of the soft palate treated with irradiation: analysis of results and complications. Radiother Oncol 9:185-194
30. Wong CS, Ang KK, Fletcher GH, et al. (1989) Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 16:657-662
31. Jaulerry C, Rodriguez J, Brunin F, et al. (1991) Results of radiation therapy in carcinoma of the base of the tongue: the Curie Institute experience with about 166 cases. Cancer 67:1532-1538
32. Bataini JP, Asselain B, Jaulerry C, et al. (1989) A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors. Radiother Oncol 14:265-277
33. Fein DA, Lee WR, Amos WR, et al. (1996) Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys 34:289-296
34. Harwood AR, Hawkins NV, Beale FA, et al. (1979) Management of advanced glottic cancer: a 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys 5:899-904
35. Freeman DE, Mancuso AA, Parsons JT, et al. (1990) Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys 19:485-490
36. Ang KK, Peters LJ (1990) Vocal cord cancer: 2B worse than not 2B? Radiother Oncol 18:365-366
37. Harwood AR, Beale FA, Cummings BJ, et al. (1983) Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys 9:311-319
38. Meoz-Mendes RT, Fletcher GH, Guillamondegui OM, et al. (1978) Analysis of the results of irradiation in the treatment of squamous cell carcinomas of the pharyngeal walls. Int J Radiat Oncol Biol Phys 4:579-585
39. Million RR, Cassisi NJ (1981) Radical irradiation for carcinoma of the pyriform sinus. Laryngoscope 91:439-450
40. Bataini P, Brugere J, Bernier J, et al. (1982) Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: experience of the Institut Curie. Int J Radiat Oncol Biol Phys 8:1277-1286
41. Ahmad K, Fayos JV (1984) Role of radiation therapy in carcinoma of the hypopharynx. Acta Radiol Oncol 23:21-26
42. Dubois JB, Guerrier B, Di Ruggiero JM, et al. (1986) Cancer of the pyriform sinus: treatment by radiation therapy alone and with surgery. Radiology 160:831-836
43. Mendenhall WM, Parsons JT, Devine JW, et al. (1987) Squamous cell carcinoma of the pyriform sinus treated with surgery and/or radiotherapy. Head Neck Surg 10:88-92
44. Croll GA, Gerristen GJ, Tiwari RM, et al. (1989) Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma: results and complications. Eur J Surg Oncol 15:350-356
45. Van den Bogaert W, Ostyn F, et al. (1985) Hypopharyngeal cancer: results of treatment with radiotherapy alone and combinations of surgery and radiotherapy. Radiother Oncol 3:311-318
46. Mendenhall WM, Parsons JT, Stringer SP, et al. (1992) Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 23:725-732
47. Parsons JT, Mendenhall WM, Stringer SP, et al. (1998) T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 40:549-552
48. Johansen LV, Grau C, Overgaard J (2000) Hypopharyngeal squamous cell carcinoma: treatment results in 138 consecutively admitted patients. Acta Oncol 39:529-536
49. Nguyen-Tan P, Le QT, Quivey JM, et al. (2001) Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 50:1172-1180
50. Ang KK (1998) Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 8:230-236
51. Nguyen LN, Ang KK (2002) Radiotherapy for cancer of the head and neck: altered fractionation regimens. Lancet Oncol 3:693-701
52. Horiot JC, Le Fur R, N'Guyen T, et al. (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231-241
53. Fu KK, Pajak TF, Trotti A, et al. (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16
54. Overgaard J, Hansen S, Spechi L, et al. (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomized controlled trial. Lancet 362:933-940
55. Pinto LH, Canary PC, Araujo CM, et al. (1991) Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21:557-562
56. Garden AS, Morrison WH, dayman GL, et al. (1996) Early squamous cell carcinoma of the hypopharynx: outcome of treatment with radiation alone to the primary disease. Head Neck 18:317-322
57. Wang CC (1988) Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys 14:1143-1146
58. Jackson SM, Weir LM, Hay JH, et al. (1997) A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43:39-46
59. Maciejewski B, Skladowski K, Pilecki B, et al. (1996) Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report on acute toxicity. Radiother Oncol 40:137-145
60. Dische S, Saunders M, Barrett A, et al. (1997) A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136
61. Bryant GP, Poulsen MG, Tripcony L, et al. (1995) Treatment decisions in T3 glottic carcinoma. Int J Radiat Oncol Biol Phys 31:285-293
62. Marks JE (1989) The endolarynx and hypopharynx. In: Moss WT, Cox JD (eds) Radiation oncology: rationale, technique, results. 6th edn. CV Mosby. St. Louis, MO, USA, pp 232-253
63. Kawashima M, Ogino T, Fujii H, et al. (1999) Local-regional control by conventional radiotherapy according to tumor volume in patients with squamous cell carcinoma of the pharyngolarynx. Jpn J Clin Oncol 29:467-173
64. The Department of Veterans Affairs Laryngeal Cancer Study Group. (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
65. Forastiere AA, Goepfert H, Maor M, et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098
66. Lee N, Xia P, Quivey JM, et al. (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12-22
67. Mell LK, Roeske JC, Mundt AJ (2003) A survey of intensity-modulated radiation therapy use in the United States. Cancer 98:204-211
68. Grégoire V, Maingon P (2004) Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of two-dimensional concepts or a reconsideration of current clinical practice. Semin Radiat Oncol 14:110-120
69. Byfield JE, Sharp TR, Frankel SS, et al. (1984) Phase I and II trial of 5-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 2:406-413
70. Kish JA, Ensley JF, Jacobs J, et al. (1985) A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP+5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56:2740-2744
71. Forastiere AA, Metch B, Schuller DE, et al. (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 10:1245-1251
72. Liverpool Head and Neck Oncology Group. (1992) A phase III randomized trial of cisplatinum, methotrexate, cisplatinum+5-FU in end stage squamous carcinoma of the head and neck. Br J Cancer 61:311-315
73. Jacobs C, Lyman G, Velez-Garcia E, et al. (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257-263
74. Vokes EE, Athanasiadis I (1996) Chemotherapy for squamous cell carcinoma of head and neck: the future is now. Ann Oncol 7:15-29
75. Domenge C, Hill C, Lefebvre JL, et al. (2000) Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 83:1594-1598
76. Paccagnella A, Orlando A, Marchioli C, et al. (1994) Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272
77. Jaulerry C, Rodriguez J, Brunin F, et al. (1992) Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys 23:483-489
78. Taylor SG, Murthy AK, Vannetzel JM, et al. (1994) Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395
79. Lawrence TS, Blackstock AW, McGinn C (2003) The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13:13-21
80. Adelstein DJ, Saxton JP, Lavertu P, et al. (1997) A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19:567-575
81. Adelstein DJ, Lavertu P, Saxton JP, et al. (2000) Mature results of phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88:876-883
82. Britzel DM, Albers ME, Fisher SR, et al. (1998) Hyper-fractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804
83. Wendt TG, Grabenbauer GG, Rodel CM, et al. (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318-1324
84. Staar S, Rudat V, Stuetzer H, et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy. Results of a multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50:1161-1171
85. Al-Sarraf M, LeBlanc M, Giri PG, et al. (1998) Chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer: Phase III randomized Intergroup study (0099) (SWOG 8892. RTOG 8817, ECOG 2388). J Clin Oncol 16:1310-1317
86. Lin JC, Jan JS, Hsu CY, et al. (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21:631-637
87. Calais G, Alfonsi M, Bardet E, et al. (1999) Randomized trial of radiation therapy versus concurrent chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086
88. Merlano M, Benasso M, Corvo R, et al. (1996) Five-year update of randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589
89. Jeremic B, Shibamoto Y, Milicic B, et al. (2000) Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18:1458-1464
90. Adelstein DJ, Li Y, Adams GL, et al. (2003) An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresec-table squamous cell head and neck cancer. J Clin Oncol 21:92-98
91. Huncharek M, Kupelnick B (2002) Combined chemotherapy versus radiation therapy alone in locally advanced nasopharyngeal carcinoma. Am J Clin Oncol 25:219-223
92. Pignon JP, Bourhis J, Domenge C, et al. (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355:949-955
93. Bourhis J, Amand C, Pignon JP, et al. (2004) Update of MACHNC (Meta-Analysis of Chemotherapy in Head and Neck Cancer) database focused on concomitant chemoradiotherapy. Proc ASCO no. 5505 (abstract)
94. Jacobs C, Goffinet DR, Goffinet L, et al. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 1987; 60:1178-1183
95. Dixon DO, Simon R (1988) Sample size considerations for studies comparing survival curves using historical controls. J Clin Epidemiol 41:1209-1213
96. List MA, Bilir P (2004) Functional outcomes in head and neck cancer. Semin Radiat Oncol 14:178-189
97. List MA, Stracks J, Colangelo L, et al. (2000) How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18:877-884
98. Plataniotis GA, Theofanopoulou ME, Kalogela-Fountzila A, et al. (2004) Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 59:1018-1026
99. Jacques Bernier J, Domenge C, Mahmut Ozsahin M, et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952
100. Kotz T, Abraham S, Beitler JJ, at al (1999) Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 125:410-413
101. Eisbruch A, Lyden T, Bradford CR, et al. (2002) Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 53:23-28
102. Nguyen NP, Moltz CC, Frank C, et al. (2003) Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15:383-388
103. Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223-231
104. Hillman RE, Walsh MJ, Wolf GT, et al. (1998) Functional out-comes following treatment for advanced laryngeal cancer. Ann Otol Rhinol Laryngol 107:2-27
105. Yokes EE, Kies MS, Haraf DJ, et al. (2000) Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18:1652-1661
106. Machtay M, Rosenthal DI, Hershock D, et al. (2002) Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 20:3964-3971
107. Yokes EE, Stenson K, Rosen FR, et al. (2003) Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21:320-326
108. Snyderman CH (2003) Nutrition and head and neck cancer. Current Oncol Rep 5:158-163
109. Maguire PD, Myerson MB, Neal CR, et al. (2004) Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community. Int J Radiat Oncol Biol Phys 58:698-704
110. McConnell Greven K (2004) Positron-emission tomography for head and neck cancer. Semin Radiat Oncol 14:121-129
111. Ang KK, Berkey BA, Tu XY, et al. (2002) Impact of epidermal growth factor receptor expression on survival and patterns of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350-7356
112. Housset M, Baillet F, Dessard-Diana B, et al. (1987) A retrospective study of three treatment techniques for T1-T2 base of tongue lesions: surgery plus postoperative radiation, external radiation plus interstitial implantation and external radiation alone. Int J Radiat Oncol Biol Phys 13:511-516
113. Samant S, Kumar P, Wan J, et al. (1999) Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 21:595-601
114. Adelstein DJ, Saxton JP, Lavertu P, et al. (2002) Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 20:1405-1410
115. Hitt A, Lopez-Pousa A, Rodriguez M, et al. (2003) Phase III study comparing cisplatin (P) and 5-fluorouracil (F) versus P, F and paclitaxel (T) as induction therapy in locally advanced head and neck cancer. Proc ASCO 22:496a (abstract)
116. Burtness BA, Li Y, Flood W, et al. (2002) Phase III trial comparing cisplatin (C) + placebo (P) + anti-epidermal growth factor antibody (EGF-R) C225 in patients (pts) with recurrent or metastatic/recurrent head and neck cancer. Proc ASCO 21:226a (abstract)
117. Bensadoun RJ, Etienne MC, Dassonville O, et al. (1998) Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. Int J Radiat Oncol Biol Phys 42:237-245
118. Denis F, Garaud P, Bardet E, et al. (2004) Final results of French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69-76
119. Trorri A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47:1-12
120. List MA, D'Antonio LL, Cella DF, et al. (1996) The performance status scale for head and neck cancer therapy - Head and Neck scale. A study of utility and validity. Cancer 77:2294-2301
121. List MA, Ritter-Sterr CA, Baker TM, et al. (1996) Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck 18:1-10
122. Chao KSC, Wippold FJ II, Ozyigit G, et al. (2002) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174-1184
123. Gregoire V, Levendag P, Ang KK, et al. (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227-236
124. Chao KSC, Ozyigit G, Tran BN, et al. (2003) Patterns of failure in patients receiving definitive and postoperative IMRT for head-hand-neck cancer. Int J Radiat Oncol Biol Phys 55:312-321
125. Goodwin WJ (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110 (Suppl 93):1-18
126. Gilbert J, Forastiere AA (2004) Organ preservation for cancer of the larynx: current indications and future directions. Semin Radiat Oncol 14:167-177
127. Gokhale AS, Lavertu P (2001) Surgical salvage after chemoradiation of head and neck cancer: complications and outcomes. Current Oncol Rep 3:72-76
128. Lavertu P, Bonafede JP, Adelstein D, et al. (1998) Comparison of surgical complications after organ-preservation therapy in patients with stage III and IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124:401-406